Inflammation in adipose tissue and fatty acid anabolism: When enough is enough!

Hormone and Metabolic Research

Volumn 45, Issue 13, 2013, Pages 1009-1019

  Ortega, F J ^a,b   Fernandez Real J M ^a,b  

^a GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

adipogenesis; adipokines; cell senescence; lipogenesis; lymphocytes; macrophages; obesity

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; CALGRANULIN; CALGRANULIN A; CALGRANULIN B; CCAAT ENHANCER BINDING PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTOFERRIN; MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; THYROID HORMONE;

ADIPOCYTE; ADIPOSE TISSUE; BIOSYNTHESIS; CELL DENSITY; CELL INFILTRATION; CYTOKINE RELEASE; ENERGY CONSUMPTION; FATTY ACID ANABOLISM; FATTY ACID METABOLISM; GLUCOSE METABOLISM; HORMONE RELEASE; HUMAN; HYPOXEMIA; IMMUNOCOMPETENT CELL; INFLAMMATION; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; LIPOLYSIS; METABOLIC DISORDER; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; SENESCENCE;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; FATTY ACIDS; HUMANS; INFLAMMATION; OBESITY; PANNICULITIS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 84890517479     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0033-1358690     Document Type: Review

References (151)

1. Perez-Perez R., Ortega-Delgado F. J., Garcia-Santos E., Lopez J. A., Camafeita E., Ricart W., Fernandez-Real J. M., Peral B. Differential proteomics of omental and subcutaneous adipose tissue reflects their unalike biochemical and metabolic properties. J Proteome Res: 2009; 8 1682 1693
2. Weiss R. Fat distribution and storage: how much, where, and how? Eur J Endocrinol: 2007; 157 01 S39 S45 (Pubitemid 47434129)
3. Tchernof A., Despres J. P. Pathophysiology of human visceral obesity: an update. Physiol Rev: 2013; 93 359 404
4. Fox C. S., Massaro J. M., Hoffmann U., Pou K. M., Maurovich-Horvat P., Liu C. Y., Vasan R. S., Murabito J. M., Meigs J. B., Cupples L. A., D'Agostino R. B. Sr, O'Donnell C. J. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation: 2007; 116 39 48 (Pubitemid 47016245)
5. Arner P. Insulin resistance in type 2 diabetes: role of fatty acids. Diabetes Metab Res Rev: 2002; 18 02 S5 S9 (Pubitemid 34467308)
6. Patel P., Abate N. Role of subcutaneous adipose tissue in the pathogenesis of insulin resistance. J Obes: 2013; 2013 489187
7. Mobbs C. V., Makimura H. Block the FAS, lose the fat. Nat Med: 2002; 8 335 336 (Pubitemid 34407025)
8. Nishimura S., Manabe I., Nagasaki M., Hosoya Y., Yamashita H., Fujita H., Ohsugi M., Tobe K., Kadowaki T., Nagai R., Sugiura S. Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes: 2007; 56 1517 1526 (Pubitemid 46842598)
9. Fajas L. Adipogenesis: a cross-talk between cell proliferation and cell differentiation. Ann Med: 2003; 35 79 85 (Pubitemid 36638210)
10. Hillgartner F. B., Salati L. M., Goodridge A. G. Physiological and molecular mechanisms involved in nutritional regulation of fatty acid synthesis. Physiol Rev: 1995; 75 47 76
11. Towle H. C., Kaytor E. N., Shih H. M. Regulation of the expression of lipogenic enzyme genes by carbohydrate. Annu Rev Nutr: 1997; 17 405 433 (Pubitemid 27328807)
12. Giorgino F., Laviola L., Eriksson J. W. Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies. Acta Physiol Scand: 2005; 183 13 30 (Pubitemid 40188033)
13. Wang Y., Jones Voy B., Urs S., Kim S., Soltani-Bejnood M., Quigley N., Heo Y. R., Standridge M., Andersen B., Dhar M., Joshi R., Wortman P., Taylor J. W., Chun J., Leuze M., Claycombe K., Saxton A. M., Moustaid-Moussa N. The human fatty acid synthase gene and de novo lipogenesis are coordinately regulated in human adipose tissue. J Nutr: 2004; 134 1032 1038 (Pubitemid 38619935)
14. Claycombe K. J., Jones B. H., Standridge M. K., Guo Y., Chun J. T., Taylor J. W., Moustaid-Moussa N. Insulin increases fatty acid synthase gene transcription in human adipocytes. Am J Physiol: 1998; 274 R1253 R1259
15. Maier T., Jenni S., Ban N. Architecture of mammalian fatty acid synthase at 4.5 A resolution. Science: 2006; 311 1258 1262 (Pubitemid 43334709)
16. Menendez J. A., Vazquez-Martin A., Ortega F. J., Fernandez-Real J. M. Fatty Acid Synthase: Association with Insulin Resistance, Type 2 Diabetes, and Cancer. Clin Chem: 2009; 55 425 438
17. Berndt J., Kovacs P., Ruschke K., Kloting N., Fasshauer M., Schon M. R., Korner A., Stumvoll M., Bluher M. Fatty acid synthase gene expression in human adipose tissue: association with obesity and type 2 diabetes. Diabetologia: 2007; 50 1472 1480 (Pubitemid 46879018)
18. Guichard C., Dugail I., Le Liepvre X., Lavau M. Genetic regulation of fatty acid synthetase expression in adipose tissue: overtranscription of the gene in genetically obese rats. J Lipid Res: 1992; 33 679 687
19. Penicaud L., Ferre P., Assimacopoulos-Jeannet F., Perdereau D., Leturque A., Jeanrenaud B., Picon L., Girard J. Increased gene expression of lipogenic enzymes and glucose transporter in white adipose tissue of suckling and weaned obese Zucker rats. Biochem J: 1991; 279 Pt 1 303 308
20. Haslam D. W., James W. P. Obesity. Lancet: 2005; 366 1197 1209 (Pubitemid 41393598)
21. Miranda P. J., DeFronzo R. A., Califf R. M., Guyton J. R. Metabolic syndrome: definition, pathophysiology, and mechanisms. Am Heart J: 2005; 149 33 45 (Pubitemid 40126488)
22. Asterholm I. W., Halberg N., Scherer P. E. Mouse Models of Lipodystrophy Key reagents for the understanding of the metabolic syndrome. Drug Discov Today Dis Models: 2007; 4 17 24 (Pubitemid 350286531)
23. Medina-Gomez G., Vidal-Puig A. Adipose tissue as a therapeutic target in obesity. Endocrinol Nutr: 2009; 56 404 411
24. Kim J. Y., van de Wall E., Laplante M., Azzara A., Trujillo M. E., Hofmann S. M., Schraw T., Durand J. L., Li H., Li G., Jelicks L. A., Mehler M. F., Hui D. Y., Deshaies Y., Shulman G. I., Schwartz G. J., Scherer P. E. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest: 2007; 117 2621 2637 (Pubitemid 47494363)
25. Lowell B. B. PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function. Cell: 1999; 99 239 242 (Pubitemid 29519902)
26. Nolan J. J., Ludvik B., Beerdsen P., Joyce M., Olefsky J. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med: 1994; 331 1188 1193 (Pubitemid 24331336)
27. Virtue S., Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome - an allostatic perspective. Biochim Biophys Acta: 2010; 1801 338 349
28. Gregor M. F., Hotamisligil G. S. Inflammatory Mechanisms in Obesity. Annu Rev Immunol: 2011; 29 415 445
29. Wellen K. E., Hotamisligil G. S. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest: 2003; 112 1785 1788 (Pubitemid 38063699)
30. Nadler S. T., Stoehr J. P., Schueler K. L., Tanimoto G., Yandell B. S., Attie A. D. The expression of adipogenic genes is decreased in obesity and diabetes mellitus. Proc Natl Acad Sci USA: 2000; 97 11371 11376
31. Moreno-Navarrete J. M., Botas P., Valdes S., Ortega F. J., Delgado E., Vazquez-Martin A., Bassols J., Pardo G., Ricart W., Menendez J. A., Fernandez-Real J. M. Val1483Ile in FASN gene is linked to central obesity and insulin sensitivity in adult white men. Obesity (Silver Spring): 2009; 17 1755 1761
32. Fernandez-Real J. M., Izquierdo M., Moreno-Navarrete J. M., Gorostiaga E., Ortega F., Martinez C., Idoate F., Ricart W., Ibanez J. Circulating soluble transferrin receptor concentration decreases after exercise-induced improvement of insulin sensitivity in obese individuals. Int J Obes (Lond): 2009; 33 768 774
33. Rossmeislova L., Malisova L., Kracmerova J., Tencerova M., Kovacova Z., Koc M., Siklova-Vitkova M., Viquerie N., Langin D., Stich V. Weight loss improves the adipogenic capacity of human preadipocytes and modulates their secretory profile. Diabetes: 2013; 62 1990 1995
34. Roberts R., Hodson L., Dennis A. L., Neville M. J., Humphreys S. M., Harnden K. E., Micklem K. J., Frayn K. N. Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans. Diabetologia: 2009; 52 882 890
35. Suganami T., Tanaka M., Ogawa Y. Adipose tissue inflammation and ectopic lipid accumulation. Endocr J: 2012; 59 849 857
36. Liu L. H., Wang X. K., Hu Y. D., Kang J. L., Wang L. L., Li S. Effects of a fatty acid synthase inhibitor on adipocyte differentiation of mouse 3T3-L1 cells. Acta Pharmacol Sin: 2004; 25 1052 1057 (Pubitemid 39071113)
37. Letexier D., Pinteur C., Large V., Frering V., Beylot M. Comparison of the expression and activity of the lipogenic pathway in human and rat adipose tissue. J Lipid Res: 2003; 44 2127 2134 (Pubitemid 37509628)
38. Eissing L., Scherer T., Todter K., Knippschild U., Greve J. W., Buurman W. A., Pinnschmidt H. O., Rensen S. S., Wolf A. M., Bartelt A., Heeren J., Buettner C., Scheja L. De novo lipogenesis in human fat and liver is linked to ChREBP-beta and metabolic health. Nat Commun: 2013; 4 1528
39. Ferre P., Foufelle F. SREBP-1c transcription factor and lipid homeostasis: clinical perspective. Horm Res: 2007; 68 72 82 (Pubitemid 47026704)
40. Sewter C., Berger D., Considine R. V., Medina G., Rochford J., Ciaraldi T., Henry R., Dohm L., Flier J. S., O'Rahilly S., Vidal-Puig A. J. Human obesity and type 2 diabetes are associated with alterations in SREBP1 isoform expression that are reproduced ex vivo by tumor necrosis factor-alpha. Diabetes: 2002; 51 1035 1041 (Pubitemid 34438347)
41. Soukas A., Cohen P., Socci N. D., Friedman J. M. Leptin-specific patterns of gene expression in white adipose tissue. Genes Dev: 2000; 14 963 980 (Pubitemid 30253005)
42. Nadler S. T., Attie A. D. Please pass the chips: genomic insights into obesity and diabetes. J Nutr: 2001; 131 2078 2081 (Pubitemid 32720633)
43. Ortega F. J., Mayas D., Moreno-Navarrete J. M., Catalan V., Gomez-Ambrosi J., Esteve E., Rodriguez-Hermosa J. I., Ruiz B., Ricart W., Peral B., Fruhbeck G., Tinahones F. J., Fernandez-Real J. M. The gene expression of the main lipogenic enzymes is downregulated in visceral adipose tissue of obese subjects. Obesity (Silver Spring): 2010; 18 13 20
44. Doerrler W., Feingold K. R., Grunfeld C. Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms. Cytokine: 1994; 6 478 484 (Pubitemid 24306961)
45. Ruan H., Hacohen N., Golub T. R., Van Parijs L., Lodish H. F. Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory. Diabetes: 2002; 51 1319 1336 (Pubitemid 34826596)
46. Minehira K., Vega N., Vidal H., Acheson K., Tappy L. Effect of carbohydrate overfeeding on whole body macronutrient metabolism and expression of lipogenic enzymes in adipose tissue of lean and overweight humans. Int J Obes Relat Metab Disord: 2004; 28 1291 1298 (Pubitemid 39389587)
47. Zhang W., Della-Fera M. A., Hartzell D. L., Hausman D., Baile C. A. Adipose tissue gene expression profiles in ob/ob mice treated with leptin. Life Sci: 2008; 83 35 42
48. Ortega F. J., Moreno-Navarrete J. M., Mayas D., Garcia-Santos E., Gomez-Serrano M., Rodriguez-Hermosa J. I., Ruiz B., Ricart W., Tinahones F. J., Fruhbeck G., Peral B., Fernandez-Real J. M. Breast cancer 1 (BrCa1) may be behind decreased lipogenesis in adipose tissue from obese subjects. PLoS One: 2012; 7 e33233
49. Brunet J., Vazquez-Martin A., Colomer R., Grana-Suarez B., Martin-Castillo B., Menendez J. A. BRCA1 and acetyl-CoA carboxylase: the metabolic syndrome of breast cancer. Mol Carcinog: 2008; 47 157 163 (Pubitemid 351231444)
50. Moreau K., Dizin E., Ray H., Luquain C., Lefai E., Foufelle F., Billaud M., Lenoir G. M., Venezia N. D. BRCA1 affects lipid synthesis through its interaction with acetyl-CoA carboxylase. J Biol Chem: 2006; 281 3172 3181 (Pubitemid 43845927)
51. Bae I., Fan S., Meng Q., Rih J. K., Kim H. J., Kang H. J., Xu J., Goldberg I. D., Jaiswal A. K., Rosen E. M. BRCA1 induces antioxidant gene expression and resistance to oxidative stress. Cancer Res: 2004; 64 7893 7909 (Pubitemid 39446923)
52. Moreno-Navarrete J. M., Ortega F. J., Ricart W., Fernandez-Real J. M. LactoÂ-ferrin increases (172Thr)AMPK phosphorylation and insulin-induced (p473Ser)AKT while impairing adipocyte differentiation. Int J Obes (Lond): 2009; 33 991 1000
53. Jequier E. Leptin signaling, adiposity, and energy balance. Ann N Y Acad Sci: 2002; 967 379 388 (Pubitemid 34721923)
54. Minokoshi Y., Kim Y. B., Peroni O. D., Fryer L. G., Muller C., Carling D., Kahn B. B. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature: 2002; 415 339 343 (Pubitemid 34087557)
55. Cohen P., Friedman J. M. Leptin and the control of metabolism: role for stearoyl-CoA desaturase-1 (SCD-1). J Nutr: 2004; 134 2455S 2463S (Pubitemid 39201621)
56. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J. M. Positional cloning of the mouse obese gene and its human homologue. Nature: 1994; 372 425 432 (Pubitemid 24365442)
57. Aleixandre de Artinano A., Miguel Castro M. Experimental rat models to study the metabolic syndrome. Br J Nutr: 2009; 102 1246 1253
58. Leibel R. L. Molecular physiology of weight regulation in mice and humans. Int J Obes (Lond): 2008; 32 (Suppl 7) S98 S108
59. Clement K., Vaisse C., Lahlou N., Cabrol S., Pelloux V., Cassuto D., Gourmelen M., Dina C., Chambaz J., Lacorte J. M., Basdevant A., Bougneres P., Lebouc Y., Froguel P., Guy-Grand B. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature: 1998; 392 398 401 (Pubitemid 28168737)
60. Dahlman I., Arner P. Obesity and polymorphisms in genes regulating human adipose tissue. Int J Obes (Lond): 2007; 31 1629 1641 (Pubitemid 350023156)
61. Oppenheimer J. H., Schwartz H. L., Lane J. T., Thompson M. P. Functional relationship of thyroid hormone-induced lipogenesis, lipolysis, and thermogenesis in the rat. J Clin Invest: 1991; 87 125 132
62. Biondi B. Thyroid and obesity: an intriguing relationship. J Clin Endocrinol Metab: 2010; 95 3614 3617
63. Reinehr T. Obesity and thyroid function. Mol Cell Endocrinol: 2010; 316 165 171
64. De Pergola G., Ciampolillo A., Paolotti S., Trerotoli P., Giorgino R. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrinol (Oxf): 2007; 67 265 269 (Pubitemid 47076304)
65. Bray G. A., Fisher D. A., Chopra I. J. Relation of thyroid hormones to body-weight. Lancet: 1976; 1 1206 1208
66. Macek Jilkova Z., Pavelka S., Flachs P., Hensler M., Kus V., Kopecky J. Modulation of type I iodothyronine 5′-deiodinase activity in white adipose tissue by nutrition: possible involvement of leptin. Physiol Res: 2009; 59 561 569
67. Menendez J. A., Vazquez-Martin A., Ortega F. J., Fernandez-Real J. M. Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer. Clin Chem: 2009; 55 425 438
68. Cabanelas A., Lisboa P. C., Moura E. G., Pazos-Moura C. C. Leptin acute modulation of the 5′-deiodinase activities in hypothalamus, pituitary and brown adipose tissue of fed rats. Horm Metab Res: 2006; 38 481 485 (Pubitemid 44378787)
69. Waters K. M., Miller C. W., Ntambi J. M. Localization of a negative thyroid hormone-response region in hepatic stearoyl-CoA desaturase gene 1. Biochem Biophys Res Commun: 1997; 233 838 843 (Pubitemid 27217741)
70. Biddinger S. B., Miyazaki M., Boucher J., Ntambi J. M., Kahn C. R. Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c. Diabetes: 2006; 55 2032 2041 (Pubitemid 44509977)
71. Poulain-Godefroy O., Lecoeur C., Pattou F., Fruhbeck G., Froguel P. Inflammation is associated with a decrease of lipogenic factors in omental fat in women. Am J Physiol Regul Integr Comp Physiol: 2008; 295 R1 R7
72. Hosogai N., Fukuhara A., Oshima K., Miyata Y., Tanaka S., Segawa K., Furukawa S., Tochino Y., Komuro R., Matsuda M., Shimomura I. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes: 2007; 56 901 911 (Pubitemid 46525054)
73. Helmlinger G., Yuan F., Dellian M., Jain R. K. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med. 19973 177-182
74. Wilkosz S., Ireland G., Khwaja N., Walker M., Butt R., de Giorgio-Miller A., Herrick S. E. A comparative study of the structure of human and murine greater omentum. Anat Embryol (Berl): 2005; 209 251 261 (Pubitemid 40558098)
75. Darimont C., Avanti O., Blancher F., Wagniere S., Mansourian R., Zbinden I., Leone-Vautravers P., Fuerholz A., Giusti V., Mace K. Contribution of mesothelial cells in the expression of inflammatory-related factors in omental adipose tissue of obese subjects. Int J Obes (Lond): 2008; 32 112 120
76. Semenza G. L. Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1. J Clin Invest: 2000; 106 809 812
77. Semenza G. L. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene: 2010; 29 625 634
78. Rius J., Guma M., Schachtrup C., Akassoglou K., Zinkernagel A. S., Nizet V., Johnson R. S., Haddad G. G., Karin M. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature: 2008; 453 807 811 (Pubitemid 351793778)
79. McNamee E. N., Korns Johnson D., Homann D., Clambey E. T. Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function. Immunol Res: 2013; 55 58 70
80. Lewis J. S., Lee J. A., Underwood J. C., Harris A. L., Lewis C. E. Macrophage responses to hypoxia: relevance to disease mechanisms. J Leukoc Biol: 1999; 66 889 900 (Pubitemid 30010512)
81. Ye J., Gimble J. M. Regulation of stem cell differentiation in adipose tissue by chronic inflammation. Clin Exp Pharmacol Physiol: 2011; 38 872 878
82. Olson N., van der Vliet A. Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease. Nitric Oxide: 2011; 25 125 137
83. Taylor C. T., Moncada S. Nitric oxide, cytochrome C oxidase, and the cellular response to hypoxia. Arterioscler Thromb Vasc Biol: 2010; 30 643 647
84. Dai Z., Wu Z., Yang Y., Wang J., Satterfield M. C., Meininger C. J., Bazer F. W., Wu G. Nitric oxide and energy metabolism in mammals. Biofactors: 2013; 39 383 391
85. Elizalde M., Ryden M., van Harmelen V., Eneroth P., Gyllenhammar H., Holm C., Ramel S., Olund A., Arner P., Andersson K. Expression of nitric oxide synthases in subcutaneous adipose tissue of nonobese and obese humans. J Lipid Res: 2000; 41 1244 1251 (Pubitemid 30666890)
86. Marchesi C., Ebrahimian T., Angulo O., Paradis P., Schiffrin E. L. Endothelial nitric oxide synthase uncoupling and perivascular adipose oxidative stress and inflammation contribute to vascular dysfunction in a rodent model of metabolic syndrome. Hypertension: 2009; 54 1384 1392
87. Bondia-Pons I., Ryan L., Martinez J. A. Oxidative stress and inflammation interactions in human obesity. J Physiol Biochem: 2012; 68 701 711
88. Stefanovic A., Kotur-Stevuljevic J., Spasic S., Bogavac-Stanojevic N., Bujisic N. The influence of obesity on the oxidative stress status and the concentration of leptin in type 2 diabetes mellitus patients. Diabetes Res Clin Pract: 2008; 79 156 163
89. Krawczyk S. A., Haller J. F., Ferrante T., Zoeller R. A., Corkey B. E. Reactive oxygen species facilitate translocation of hormone sensitive lipase to the lipid droplet during lipolysis in human differentiated adipocytes. PLoS One: 2012; 7 e34904
90. Carmiel-Haggai M., Cederbaum A. I., Nieto N. A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. FASEB J: 2005; 19 136 138 (Pubitemid 40069943)
91. Vincent H. K., Taylor A. G. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (Lond): 2006; 30 400 418
92. Morrow J. D. Is oxidant stress a connection between obesity and atherosclerosis? Arterioscler Thromb Vasc Biol: 2003; 23 368 370 (Pubitemid 36337207)
93. Moreno-Navarrete J. M., Ortega F., Sabater M., Ricart W., Fernandez-Real J. M. Telomere length of subcutaneous adipose tissue cells is shorter in obese and formerly obese subjects. Int J Obes (Lond): 2010; 34 1345 1348
94. Minamino T., Orimo M., Shimizu I., Kunieda T., Yokoyama M., Ito T., Nojima A., Nabetani A., Oike Y., Matsubara H., Ishikawa F., Komuro I. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat Med: 2009; 15 1082 1087
95. Ryan K. M., Ernst M. K., Rice N. R., Vousden K. H. Role of NF-kappaB in p53-mediated programmed cell death. Nature: 2000; 404 892 897 (Pubitemid 30230343)
96. Molchadsky A., Shats I., Goldfinger N., Pevsner-Fischer M., Olson M., Rinon A., Tzahor E., Lozano G., Zipori D., Sarig R., Rotter V. p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner. PLoS One: 2008; 3 e3707
97. Bazuine M., Stenkula K. G., Cam M., Arroyo M., Cushman S. W. Guardian of corpulence: a hypothesis on p53 signaling in the fat cell. Clin Lipidol. 20094 231-243
98. Schwartzenberg-Bar-Yoseph F., Armoni M., Karnieli E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res: 2004; 64 2627 2633 (Pubitemid 38523921)
99. Sell H., Eckel J. Adipose tissue inflammation: novel insight into the role of macrophages and lymphocytes. Curr Opin Clin Nutr Metab Care: 2010; 13 366 370
100. Panee J. Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes. Cytokine: 2012; 60 1 12
101. Christiansen T., Richelsen B., Bruun J. M. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes (Lond): 2005; 29 146 150 (Pubitemid 40065478)
102. Famulla S., Horrighs A., Cramer A., Sell H., Eckel J. Hypoxia reduces the response of human adipocytes towards TNFalpha resulting in reduced NF-kappaB signaling and MCP-1 secretion. Int J Obes (Lond): 2012; 36 986 992
103. Weisberg S. P., McCann D., Desai M., Rosenbaum M., Leibel R. L., Ferrante A. W. Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest: 2003; 112 1796 1808 (Pubitemid 38063703)
104. Cancello R., Henegar C., Viguerie N., Taleb S., Poitou C., Rouault C., Coupaye M., Pelloux V., Hugol D., Bouillot J. L., Bouloumie A., Barbatelli G., Cinti S., Svensson P. A., Barsh G. S., Zucker J. D., Basdevant A., Langin D., Clement K. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes: 2005; 54 2277 2286 (Pubitemid 41134253)
105. Gordon S. Alternative activation of macrophages. Nat Rev Immunol: 2003; 3 23 35 (Pubitemid 37328697)
106. Mosser D. M., Edwards J. P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol: 2008; 8 958 969
107. Fujisaka S., Usui I., Bukhari A., Ikutani M., Oya T., Kanatani Y., Tsuneyama K., Nagai Y., Takatsu K., Urakaze M., Kobayashi M., Tobe K. Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes: 2009; 58 2574 2582
108. Aron-Wisnewsky J., Tordjman J., Poitou C., Darakhshan F., Hugol D., Basdevant A., Aissat A., Guerre-Millo M., Clement K. Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss. J Clin Endocrinol Metab: 2009; 94 4619 4623
109. Prieur X., Mok C. Y., Velagapudi V. R., Nunez V., Fuentes L., Montaner D., Ishikawa K., Camacho A., Barbarroja N., O'Rahilly S., Sethi J. K., Dopazo J., Oresic M., Ricote M., Vidal-Puig A. Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes: 2011; 60 797 809
110. Han M. S., Jung D. Y., Morel C., Lakhani S. A., Kim J. K., Flavell R. A., Davis R. J. JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science: 2013; 339 218 222
111. Anderson E. K., Gutierrez D. A., Hasty A. H. Adipose tissue recruitment of leukocytes. Curr Opin Lipidol: 2010; 21 172 177
112. Feuerer M., Herrero L., Cipolletta D., Naaz A., Wong J., Nayer A., Lee J., Goldfine A. B., Benoist C., Shoelson S., Mathis D. Lean but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med: 2009; 15 930 939
113. Ghani S., Feuerer M., Doebis C., Lauer U., Loddenkemper C., Huehn J., Hamann A., Syrbe U. T cells as pioneers: antigen-specific T cells condition inflamed sites for high-rate antigen-non-specific effector cell recruitment. Immunology: 2009; 128 e870 e880
114. DeFuria J., Belkina A. C., Jagannathan-Bogdan M., Snyder-Cappione J., Carr J. D., Nersesova Y. R., Markham D., Strissel K. J., Watkins A. A., Zhu M., Allen J., Bouchard J., Toraldo G., Jasuja R., Obin M. S., McDonnell M. E., Apovian C., Denis G. V., Nikolajczyk B. S. B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci USA: 2013; 110 5133 5138
115. Chatzigeorgiou A., Karalis K. P., Bornstein S. R., Chavakis T. Lymphocytes in obesity-related adipose tissue inflammation. Diabetologia: 2012; 55 2583 2592
116. Fernandez-Real J. M., Pickup J. C. Innate immunity, insulin resistance and type 2 diabetes. Diabetologia: 2012; 55 273 278
117. Gubern C., Lopez-Bermejo A., Biarnes J., Vendrell J., Ricart W., Fernandez-Real J. M. Natural antibiotics and insulin sensitivity: the role of bactericidal/permeability-increasing protein. Diabetes: 2006; 55 216 224 (Pubitemid 43343318)
118. Lopez-Bermejo A., Chico-Julia B., Castro A., Recasens M., Esteve E., Biarnes J., Casamitjana R., Ricart W., Fernandez-Real J. M. Alpha defensins 1, 2, and 3: potential roles in dyslipidemia and vascular dysfunction in humans. Arterioscler Thromb Vasc Biol: 2007; 27 1166 1171 (Pubitemid 46641973)
119. Moreno-Navarrete J. M., Martinez-Barricarte R., Catalan V., Sabater M., Gomez-Ambrosi J., Ortega F. J., Ricart W., Bluher M., Fruhbeck G., Rodriguez de Cordoba S., Fernandez-Real J. M. Complement factor H is expressed in adipose tissue in association with insulin resistance. Diabetes: 2010; 59 200 209
120. Moreno-Navarrete J. M., Ortega F. J., Bassols J., Castro A., Ricart W., Fernandez-Real J. M. Association of circulating lactoferrin concentration and 2 nonsynonymous LTF gene polymorphisms with dyslipidemia in men depends on glucose-tolerance status. Clin Chem: 2008; 54 301 309 (Pubitemid 351302631)
121. Mingrone G., Panunzi S., De Gaetano A., Guidone C., Iaconelli A., Leccesi L., Nanni G., Pomp A., Castagneto M., Ghirlanda G., Rubino F. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med: 2012; 366 1577 1585
122. Moschen A. R., Molnar C., Wolf A. M., Weiss H., Graziadei I., Kaser S., Ebenbichler C. F., Stadlmann S., Moser P. L., Tilg H. Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression. J Hepatol: 2009; 51 765 777
123. Tilg H., Moschen A. R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol: 2006; 6 772 783 (Pubitemid 44453463)
124. Striz I., Trebichavsky I. Calprotectin - a pleiotropic molecule in acute and chronic inflammation. Physiol Res: 2004; 53 245 253 (Pubitemid 38797280)
125. Ryckman C., Vandal K., Rouleau P., Talbot M., Tessier P. A. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol: 2003; 170 3233 3242 (Pubitemid 36302201)
126. Johne B., Fagerhol M. K., Lyberg T., Prydz H., Brandtzaeg P., Naess-Andresen C. F., Dale I. Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol: 1997; 50 113 123 (Pubitemid 27454995)
127. Mortensen O. H., Nielsen A. R., Erikstrup C., Plomgaard P., Fischer C. P., Krogh-Madsen R., Lindegaard B., Petersen A. M., Taudorf S., Pedersen B. K. Calprotectin - a novel marker of obesity. PLoS One: 2009; 4 e7419
128. Catalan V., Gomez-Ambrosi J., Rodriguez A., Ramirez B., Rotellar F., Valenti V., Silva C., Gil M. J., Fernandez-Real J. M., Salvador J., Fruhbeck G. Increased levels of calprotectin in obesity are related to macrophage content: impact on inflammation and effect of weight loss. Mol Med: 2011; 17 1157 1167
129. Ortega F. J., Mercader J. M., Moreno-Navarrete J. M., Sabater M., Pueyo N., Valdes S., Ruiz B., Luche E., Naon D., Ricart W., Botas P., Delgado E., Burcelin R., Fruhbeck G., Bosch F., Mingrone G., Zorzano A., Fernandez-Real J. M. Targeting the association of calgranulin B (S100A9) with insulin resistance and type 2 diabetes. J Mol Med (Berl): 2013; 91 523 534
130. Ortega F. J., Sabater M., Moreno-Navarrete J. M., Pueyo N., Botas P., Delgado E., Ricart W., Fruhbeck G., Fernandez-Real J. M. Serum and urinary concentrations of calprotectin as markers of insulin resistance and type 2 diabetes. Eur J Endocrinol: 2012; 167 569 578
131. Marenholz I., Heizmann C. W., Fritz G. S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun: 2004; 322 1111 1122 (Pubitemid 39164640)
132. Foell D., Frosch M., Sorg C., Roth J. Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin Chim Acta: 2004; 344 37 51 (Pubitemid 38626135)
133. Averill M. M., Barnhart S., Becker L., Li X., Heinecke J. W., Leboeuf R. C., Hamerman J. A., Sorg C., Kerkhoff C., Bornfeldt K. E. S100A9 Differentially Modifies Phenotypic States of Neutrophils, Macrophages, and Dendritic Cells: Implications for Atherosclerosis and Adipose Tissue Inflammation. Circulation: 2011; 123 1216 1226
134. Sjoberg A. P., Trouw L. A., Blom A. M. Complement activation and inhibition: a delicate balance. Trends Immunol: 2009; 30 83 90
135. Leal Vde O., Mafra D. Adipokines in obesity. Clin Chim Acta: 2013; 419 87 94
136. Bluher M. Clinical relevance of adipokines. Diabetes Metab J: 2012; 36 317 327
137. Bassols J., Ortega F. J., Moreno-Navarrete J. M., Peral B., Ricart W., Fernandez-Real J. M. Study of the proinflammatory role of human differentiated omental adipocytes. J Cell Biochem: 2009; 107 1107 1117
138. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun: 1999; 257 79 83 (Pubitemid 29299050)
139. Chandran M., Phillips S. A., Ciaraldi T., Henry R. R. Adiponectin: more than just another fat cell hormone? Diabetes Care: 2003; 26 2442 2450 (Pubitemid 36993340)
140. Yang W. S., Lee W. J., Funahashi T., Tanaka S., Matsuzawa Y., Chao C. L., Chen C. L., Tai T. Y., Chuang L. M. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab: 2001; 86 3815 3819 (Pubitemid 32755982)
141. Moreno-Navarrete J. M., Serrano M., Sabater M., Ortega F. J., Serino M., Pueyo N., Luche E., Waget A., Rodriguez-Hermosa J. I., Ricart W., Burcelin R., Fernandez-Real J. M. Study of lactoferrin gene expression in human and mouse adipose tissue, human preadipocytes and mouse 3T3-L1 fibroblasts. Association with adipogenic and inflammatory markers. J Nutr Biochem: 2013; 24 1266 1275
142. Ward P. P., Paz E., Conneely O. M. Multifunctional roles of lactoferrin: a critical overview. Cell Mol Life Sci: 2005; 62 2540 2548 (Pubitemid 41721229)
143. Moreno-Navarrete J. M., Ortega F. J., Bassols J., Ricart W., Fernandez-Real J. M. Decreased circulating lactoferrin in insulin resistance and altered glucose tolerance as a possible marker of neutrophil dysfunction in type 2 diabetes. J Clin Endocrinol Metab: 2009; 94 4036 4044
144. Fernandez-Real J. M., Garcia-Fuentes E., Moreno-Navarrete J. M., Murri-Pierri M., Garrido-Sanchez L., Ricart W., Tinahones F. Fat overload induces changes in circulating lactoferrin that are associated with postprandial lipemia and oxidative stress in severely obese subjects. Obesity (Silver Spring).: 2010; 18 482 488
145. Moreno-Navarrete J. M., Ortega F., Sabater M., Ricart W., Fernandez-Real J. M. Proadipogenic effects of lactoferrin in human subcutaneous and visceral preadipocytes. J Nutr Biochem: 2011; 22 1143 1149
146. Ono T., Murakoshi M., Suzuki N., Iida N., Ohdera M., Iigo M., Yoshida T., Sugiyama K., Nishino H. Potent anti-obesity effect of enteric-coated
147. Sano H., Kuroki Y. The lung collectins, SP-A and SP-D, modulate pulmonary innate immunity. Mol Immunol: 2005; 42 279 287 (Pubitemid 39626759)
148. Sorensen G. L., Hjelmborg J. B., Kyvik K. O., Fenger M., Hoj A., Bendixen C., Sorensen T. I., Holmskov U. Genetic and environmental influences of surfactant protein D serum levels. Am J Physiol Lung Cell Mol Physiol: 2006; 290 L1010 L1017 (Pubitemid 43725064)
149. Ortega F. J., Pueyo N., Moreno-Navarrete J. M., Sabater M., Rodriguez-Hermosa J. I., Ricart W., Tinahones F. J., Fernández-Real J. M. The lung innate immune gene surfactant protein-D is expressed in adipose tissue and linked to obesity status. Int J Obes (Lond): 2013; doi: 10.1038
150. Fernandez-Real J. M., Valdes S., Manco M., Chico B., Botas P., Campo A., Casamitjana R., Delgado E., Salvador J., Fruhbeck G., Mingrone G., Ricart W. Surfactant protein d, a marker of lung innate immunity, is positively associated with insulin sensitivity. Diabetes Care: 2010; 33 847 853
151. Stidsen J. V., Khorooshi R., Rahbek M. K., Kirketerp-Moller K. L., Hansen P. B., Bie P., Kejling K., Mandrup S., Hawgood S., Nielsen O., Nielsen C. H., Owens T., Holmskov U., Sorensen G. L. Surfactant protein d deficiency in mice is associated with hyperphagia, altered fat deposition, insulin resistance, and increased basal endotoxemia. PLoS One: 2012; 7 e35066